MedTrace Logo

Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease

NCT01198405 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2010-09-10

No results posted yet for this study

Summary

To investigate the mid- and long-term effect of Enhanced External Counterpulsation combined with guideline-driven standard treatment on patients documented with and/or at high risk of coronary artery disease.

Conditions

Interventions

DEVICE

Enhanced external counterpulsation

Treatment of enhanced external counterpulsation (EECP) with a prespecified protocol on top of a guideline-driven standard medical therapy. EECP Protocol is defined as a standard session of a total of 36 hours of EECP treatment, given one hour per day, six days per week. The same session is thereafter repeated at least once every year.

DRUG

Guideline-driven standard medical therapy

Standard management, both pharmacological and non-pharmacological, given according to current practice guidelines at the discretion of clinicians

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Zhi-min Du, M.D. · The 1st Affiliated Hospital of Sun Yat-sen University

  • Gui-fu Wu, M.D. & Ph.D. · The 1st Affiliated Hospital of Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-09-30
Completion
2013-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198405 on ClinicalTrials.gov